Plain-English translation of NCT06144762 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is testing a new imaging approach called radiomics—essentially advanced computer analysis of medical scans—to better detect pancreatic cancer in its early stages and monitor treatment response. The study involves taking detailed MRI images of your tumor before and after surgery, combined with blood and tissue samples, to create a detailed picture of your cancer that doctors' eyes alone might miss.
Pancreatic cancer is caught too late in most patients, often after it has already spread, which is why survival rates are very low. This study exists to develop better, non-invasive ways to spot pancreatic cancer earlier and understand each patient's unique tumor so treatment can be more personalized and effective.
You likely qualify if…
You likely don't qualify if…
You will have special MRI scans performed both before your scheduled pancreatic cancer surgery and on your removed tumor tissue in the laboratory after surgery. You will also provide blood and tissue samples for the study. The research uses these scans and samples to develop better ways to detect and understand pancreatic cancer without the need for multiple invasive biopsies.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
France